World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
86
Citations
34108
World Ranking
1237
National Ranking
646

Medicine

D-Index
88
Citations
34439
World Ranking
13008
National Ranking
6649

Alfred J. Saah publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Alfred J. Saah sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 235 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Alfred J. Saah D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Alfred J. Saah sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 86 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Alfred J. Saah is a researcher affiliated with MSD (United States) focusing primarily on medical sciences, particularly in the fields of epidemiology, surgery, molecular biology, immunology, and microbiology. Their work encompasses 37 publications in medicine with a heavy emphasis on epidemiological studies.

The scientist's major research themes include cervical cancer and HPV research, hepatitis B virus studies, genital health and disease, molecular biology techniques and applications, immunotherapy and immune responses, animal virus infections studies, and herpesvirus infections and treatments.

Alfred J. Saah has published multiple papers on the effectiveness and immunogenicity of human papillomavirus (HPV) vaccines, HPV-associated diseases, and related public health impacts. Notable recent publications include:

  • Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four Nordic countries, 2020, EClinicalMedicine
  • Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence, 2021, Vaccine
  • Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer, 2023, Vaccine
  • Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review, 2022, Expert Review of Vaccines
  • Prevalence, incidence, and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trial, 2020, Papillomavirus Research

Their frequent co-authors, contributing to collaborative research efforts, include Alain Luxembourg, Anna R. Giuliano, Christine Velicer, Elmar A. Joura, and Susanne K. Kjær.

Alfred J. Saah's publications are prominently featured in well-known scientific journals such as Vaccine, Clinical Infectious Diseases, EClinicalMedicine, Expert Review of Vaccines, and Papillomavirus Research. The Vaccine journal is the most common publication venue for their work, with five contributions.

Best Publications

  • Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

    Michael Dean;Mary Carrington;Cheryl Winkler;Gavin A. Huttley

  • Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection

    John W. Mellors;Alvaro Muñoz;Janis V. Giorgi;Joseph B. Margolick

  • Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

    Luisa L. Villa;Ronaldo L.R. Costa;Carlos A. Petta;Rosires P. Andrade

  • Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection

    Richard A. Kaslow;Mary Carrington;R. Apple;L. Park

  • KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.

    Shou-Jiang Gao;Lawrence Kingsley;Ming Li;Wei Zheng

  • The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group.

    John Phair;Alvaro Muñoz;Roger Detels;Richard Kaslow

  • Dementia in AIDS patients: Incidence and risk factors

    J. C. McArthur;D. R. Hoover;H. Bacellar;E. N. Miller

  • High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

    L. L. Villa;R. L. R. Costa;C. A. Petta;R. P. Andrade

  • Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma

    Shou Jiang Gao;Lawrence Kingsley;Donald R. Hoover;Thomas J. Spira

  • Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

    Luisa L. Villa;Kevin A. Ault;Anna R. Giuliano;Ronaldo L.R. Costa

  • Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.

    Nubia Muñoz;Ricardo Manalastas;Punee Pitisuttithum;Damrong Tresukosol

  • Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience

    Suzanne M. Garland;Susanne K. Kjaer;Nubia Muñoz;Stan L. Block

  • Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation.

    Henderson Dk;Fahey Bj;Willy M;Schmitt Jm

  • Clinical manifestations of AIDS in the ERA of pneumocystis prophylaxis

    Donald R. Hoover;Alfred J. Saah;Helena Bacellar;John Phair

  • Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain

    Justin C. McArthur;Daniel R. McClernon;Michael F. Cronin;Tish E. Nance-Sproson

  • End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age

    X Castellsague;N Munoz;P Pitisuttithum;Daron G. Ferris

  • Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

    Sven-Eric Olsson;Luisa L. Villa;Ronaldo L.R. Costa;Carlos A. Petta

  • A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

    Susanne K. Kjaer;Kristján Sigurdsson;Ole-Erik Iversen;Mauricio Hernandez-Avila

  • Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men

    A. M. Tang;N. M. H. Graham;A. J. Kirby;L. D. Mccall

  • Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease.

    Terry McNearney;Zuzana Hornickova;Richard Markham;Anahid Birdwell

  • HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages

    O. A. Selnes;E. Miller;J. McArthur;B. Gordon

Frequent Co-Authors

Donald R. Hoover
Donald R. Hoover Rutgers, The State University of New Jersey
Roger Detels
Roger Detels University of California, Los Angeles
John P. Phair
John P. Phair Northwestern University
Richard A. Kaslow
Richard A. Kaslow Yale School of Medicine
Charles R. Rinaldo
Charles R. Rinaldo University of Pittsburgh
Neil M.H. Graham
Neil M.H. Graham Regeneron (United States)
Joseph B. Margolick
Joseph B. Margolick Johns Hopkins University
Joan S. Chmiel
Joan S. Chmiel Northwestern University
Lawrence A. Kingsley
Lawrence A. Kingsley University of Pittsburgh
Alvaro Muñoz
Alvaro Muñoz Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research careers. Many students complement their immunology knowledge with nursing degrees to enhance clinical understanding and patient care skills. For those interested in transitioning into nursing without prior experience, programs like online rn programs for non nurses in florida offer flexible online options tailored for career changers.

If you're looking for faster routes into nursing, exploring the easiest accelerated nursing programs to get into can be a strategic move. These programs help students quickly gain the credentials required for advanced practice roles.

For those considering practical nursing, identifying the easiest lpn programs to get into may provide an accessible pathway into healthcare while building foundational clinical skills.

Advanced practice nurses can further specialize by finding which nurse practitioner program is easiest to enter, enabling quicker progression into roles that combine patient care with immunology insights. Together, these pathways offer diverse options for immunology graduates aiming to impact healthcare directly.

Best Scientists Citing Alfred J. Saah

Trending Scientists

Recently Published Articles